Fmoc-L-Orn(2-Cl-Z)-OH

Fmoc-L-Orn(2-Cl-Z)-OH is an Fmoc-protected L-ornithine derivative bearing a side-chain protecting group at the δ-amino position, where the orthogonal 2-chloro-benzyloxycarbonyl (2-Cl-Z) carbamate masks the nucleophilic amine while retaining the stereodefined α-amino acid framework. The molecule contains an Fmoc carbamate for N-terminal compatibility in solid-phase peptide synthesis and a second, orthogonally removable side-chain protecting group that supports controlled peptide assembly and subsequent side-chain functional elaboration. The presence of the 2-chloro substituent on the benzyloxycarbonyl group can influence deprotection and downstream reactivity compared with unsubstituted Z protection, while the amino acid ester-free carboxylic acid enables standard coupling chemistry after activation. As a chiral, orthogonally protected amino acid building block, Fmoc-L-Orn(2-Cl-Z)-OH functions as a chemically defined intermediate for constructing polyamine-containing peptides and for preparing ornithine-based analogs used in biochemical research and synthetic organic chemistry.

1. Solid-Phase Peptide Synthesis

Fmoc-L-Orn(2-Cl-Z)-OH is applied in solid-phase peptide synthesis workflows where orthogonal protection is required for incorporating ornithine residues into peptide chains. The Fmoc group enables stepwise N-terminal deprotection and peptide coupling, while the 2-Cl-Z carbamate on the side-chain δ-amine suppresses undesired branching or crosslinking during chain elongation. The free carboxylic acid participates in amide bond formation under peptide coupling conditions, allowing controlled placement of the ornithine unit for generating polycationic or charge-balanced peptide sequences. The resulting ornithine-containing peptides can serve as defined substrates for biochemical assays, as scaffolds for peptidomimetic design, and as intermediates for further side-chain derivatization after orthogonal deprotection strategies.

2. Side-Chain Functionalization

Fmoc-L-Orn(2-Cl-Z)-OH is suitable for side-chain functionalization programs that transform the ornithine δ-amino functionality into chemically distinct handles for downstream conjugation. The protected δ-amine prevents premature reactions during initial synthesis steps, enabling selective unveiling of the amine at a chosen stage to introduce acyl, sulfonyl, carbamate, or heteroatom-containing substituents. The stereodefined amino acid backbone maintains positional control of the side-chain relative to the peptide or linker framework, which is relevant for structure-function studies of cationic motifs and for constructing amino acid-based molecular adapters. Ornithine derivatives generated from this building block can be used to prepare labeled probes, affinity reagents, or functionalized peptide analogs that retain compatibility with subsequent coupling or analytical workflows.

3. Chemical Biology Probes

Fmoc-L-Orn(2-Cl-Z)-OH is employed in chemical biology research to build ornithine-rich peptide probes used for studying biomolecular recognition, binding interfaces, and post-translational modification mimicry. The orthogonally protected amines allow controlled synthesis of cationic peptide architectures that can be further equipped with reactive groups such as electrophiles, fluorophores, or bioorthogonal motifs after deprotection. The Fmoc-protected N-terminus supports reproducible peptide assembly, while the masked δ-amine helps maintain chemoselectivity during probe construction and reduces side reactions that can complicate characterization. Downstream derivatives prepared from this amino acid intermediate can function as defined reagents for target engagement studies, as standards for analytical method development, and as starting points for systematic structure-activity relationship investigations.

4. Process Chemistry Intermediate

Fmoc-L-Orn(2-Cl-Z)-OH is relevant to process chemistry and fine chemical synthesis as a protected amino acid intermediate designed for scalable, reproducible incorporation into peptide building blocks. The dual protection pattern, with an Fmoc carbamate and a 2-Cl-Z side-chain carbamate, supports manufacturing-oriented control over chemoselectivity during sequential deprotection and coupling steps. The stable, chiral amino acid framework and the presence of a carboxylic acid suitable for activation enable integration into established peptide coupling supply chains and intermediate preparation routes. Industrial or semi-industrial peptide manufacturing can use this compound to prepare ornithine-containing intermediates that later undergo standardized transformations for producing research-grade peptide reagents, peptidomimetic libraries, and specialty chemical materials derived from polyamine motifs.

5. Peptidomimetics And SAR Studies

Fmoc-L-Orn(2-Cl-Z)-OH is applied in peptidomimetic construction and structure-activity relationship studies where ornithine side-chain positioning and charge presentation are key variables. The protected δ-amine enables incorporation of the ornithine residue into analog series without uncontrolled side-chain reactions, while orthogonal deprotection supports late-stage diversification of the side-chain to tune sterics, polarity, and hydrogen-bonding patterns. The Fmoc handle supports consistent N-terminal architecture across analog sets, improving comparability of synthesized variants used in SAR workflows. Ornithine-based peptidomimetics prepared from this building block can serve as defined molecular scaffolds for fragment linking strategies, binding interface mapping, and iterative optimization of amino acid-derived molecular recognition elements.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging